HCA Healthcare, Inc. Revenue
HCA Healthcare, Inc. (HCA) reported Revenue of $19.11 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-04-29
- HCA Healthcare, Inc. revenues for the quarter ending 2026-03-31 was $19.11B, a 4.30% increase year-over-year.
- HCA Healthcare, Inc. revenues for the quarter ending 2025-12-31 was $19.51B, a 6.72% increase year-over-year.
- HCA Healthcare, Inc. revenues for the quarter ending 2025-09-30 was $19.16B, a 9.57% increase year-over-year.
- HCA Healthcare, Inc. revenues for the quarter ending 2025-06-30 was $18.61B, a 6.36% increase year-over-year.
- HCA Healthcare, Inc. revenues for fiscal 2025 was $75.60B, a 7.08% increase from fiscal 2024.
- HCA Healthcare, Inc. revenues for fiscal 2024 was $70.60B, a 8.67% increase from fiscal 2023.
- HCA Healthcare, Inc. revenues for fiscal 2023 was $64.97B, a 7.86% increase from fiscal 2022.
- HCA Healthcare, Inc. revenues for fiscal 2022 was $60.23B, a 2.52% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2026-03-31 | $19.11B 10-Q · filed 2026-04-29 | $38.62B derived: sum of 2 quarters · filed 2026-04-29 | $57.78B derived: sum of 3 quarters · filed 2026-04-29 | $76.39B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $19.51B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $38.67B derived: sum of 2 quarters · filed 2026-02-10 | $57.28B derived: sum of 3 quarters · filed 2026-02-10 | $75.60B 10-K · filed 2026-02-10 |
| 2025-09-30 | $19.16B 10-Q · filed 2025-10-30 | $37.77B derived: sum of 2 quarters · filed 2025-10-30 | $56.09B 10-Q · filed 2025-10-30 | $74.37B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $18.61B 10-Q · filed 2025-08-04 | $36.93B 10-Q · filed 2025-08-04 | $55.21B derived: sum of 3 quarters · filed 2026-04-29 | $72.70B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $18.32B 10-Q · filed 2026-04-29 | $36.61B derived: sum of 2 quarters · filed 2026-04-29 | $54.09B derived: sum of 3 quarters · filed 2026-04-29 | $71.58B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $18.29B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $35.77B derived: sum of 2 quarters · filed 2026-02-10 | $53.26B derived: sum of 3 quarters · filed 2026-02-10 | $70.60B 10-K · filed 2026-02-10 |
| 2024-09-30 | $17.49B 10-Q · filed 2025-10-30 | $34.98B derived: sum of 2 quarters · filed 2025-10-30 | $52.32B 10-Q · filed 2025-10-30 | $69.62B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | $17.49B 10-Q · filed 2025-08-04 | $34.83B 10-Q · filed 2025-08-04 | $52.13B derived: sum of 3 quarters · filed 2026-02-10 | $68.35B derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $17.34B 10-Q · filed 2025-05-01 | $34.64B derived: sum of 2 quarters · filed 2026-02-10 | $50.85B derived: sum of 3 quarters · filed 2026-02-10 | $66.72B derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $17.30B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $33.52B derived: sum of 2 quarters · filed 2026-02-10 | $49.38B derived: sum of 3 quarters · filed 2026-02-10 | $64.97B 10-K · filed 2026-02-10 |
| 2023-09-30 | $16.21B 10-Q · filed 2024-10-31 | $32.07B derived: sum of 2 quarters · filed 2024-10-31 | $47.66B 10-Q · filed 2024-10-31 | $63.16B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $15.86B 10-Q · filed 2024-07-29 | $31.45B 10-Q · filed 2024-07-29 | $46.95B derived: sum of 3 quarters · filed 2025-02-14 | $61.92B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $15.59B 10-Q · filed 2024-05-02 | $31.09B derived: sum of 2 quarters · filed 2025-02-14 | $46.06B derived: sum of 3 quarters · filed 2025-02-14 | $60.88B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $15.50B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $30.47B derived: sum of 2 quarters · filed 2025-02-14 | $45.29B derived: sum of 3 quarters · filed 2025-02-14 | $60.23B 10-K · filed 2025-02-14 |
| 2022-09-30 | $14.97B 10-Q · filed 2023-10-26 | $29.79B derived: sum of 2 quarters · filed 2023-10-26 | $44.74B 10-Q · filed 2023-10-26 | $59.80B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-06-30 | $14.82B 10-Q · filed 2023-08-02 | $29.77B 10-Q · filed 2023-08-02 | $44.83B derived: sum of 3 quarters · filed 2024-02-16 | $60.10B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-03-31 | $14.95B 10-Q · filed 2023-04-27 | $30.01B derived: sum of 2 quarters · filed 2024-02-16 | $45.28B derived: sum of 3 quarters · filed 2024-02-16 | $59.72B derived: sum of 4 quarters · filed 2024-02-16 |
| 2021-12-31 | $15.06B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $30.34B derived: sum of 2 quarters · filed 2024-02-16 | $44.77B derived: sum of 3 quarters · filed 2024-02-16 | $58.75B 10-K · filed 2024-02-16 |
| 2021-09-30 | $15.28B 10-Q · filed 2022-11-01 | $29.71B derived: sum of 2 quarters · filed 2022-11-01 | $43.69B 10-Q · filed 2022-11-01 | |
| 2021-06-30 | $14.44B 10-Q · filed 2022-08-01 | $28.41B 10-Q · filed 2022-08-01 | ||
| 2021-03-31 | $13.98B 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $51.53B 8-K · filed 2023-05-26 | |||
| 2019-12-31 | $51.34B 10-K · filed 2022-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENET HEALTHCARE CORP (THC) | United States | $20.097B | |
| Surgery Partners, Inc. (SGRY) | United States | $1.860B | -24.80 |
| Ardent Health, Inc. (ARDT) | United States | $1.478B | 17.91 |
| COMMUNITY HEALTH SYSTEMS INC (CYH) | United States | $0.405B | 1.87 |